Siemens begins shipping COVID-19 antibody test in Canada

By LabPulse.com staff writers

August 18, 2020 -- Siemens Healthineers has begun shipping its total antibody test for COVID-19 in Canada. The firm recently received Health Canada Interim Order authorization for its laboratory-based total antibody test, which detects SARS-CoV-2 immunoglobulin M and immunoglobulin G antibodies in blood in as few as 10 minutes.

The test has been shown to yield 100% sensitivity and 99.8% specificity for detecting the antibodies, Siemens said.

The test has also received U.S. Food and Drug Administration approval and the CE Mark in Europe.

Sysmex America inks distribution deal with Siemens
Sysmex America has secured a contract with Siemens Healthineers to distribute that company's Clinitek Novus automated urine chemistry analyzer in North...
Siemens wins EUA for semiquantitative SARS-CoV-2 antibody test
Siemens Healthineers has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its semiquantitative SARS-CoV-2...
Siemens revenue falls 7% in third quarter
Siemens Healthineers saw its revenue fall 7% in the company's third fiscal quarter due to the impact of the COVID-19 pandemic. The company saw a single-digit...
Siemens wins clearance in Canada for SARS-CoV-2 test
Siemens Healthineers has received authorization from Health Canada for its Fast Track Diagnostics SARS-CoV-2 Assay test kit.
Siemens coronavirus antibody test beats rivals in Public Health England study
A Siemens SARS-CoV-2 antibody test outperformed immunoassays from other, major manufacturers in a large study conducted by the U.K. government and published...

Copyright © 2020 LabPulse.com

Last Updated ls 8/18/2020 4:23:26 PM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current